$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Home
Hepatobiliary
Hepatobiliary
育龄期的女性是乙肝感染人群
2025-10-19 11:44:20
Check Details
慢性乙肝患者接受抗病毒可以预防肝癌
2025-10-19 11:44:20
Check Details
乙型肝炎:标准治疗方案和新型治疗方案
2025-10-19 11:44:20
Check Details
我国乙肝的诊断率和治疗率不足原因
2025-10-19 11:44:20
Check Details
乙肝病毒感染者死亡风险上升
2025-10-19 11:44:20
Check Details
替诺福韦+新型免疫调节剂在慢性乙肝患者中的临床试验
2025-10-19 11:44:20
Check Details
替诺福韦治疗慢性乙型肝炎可降低肝细胞癌风险
2025-10-19 11:44:20
Check Details
乙肝基因疗法公布临床数据
2025-10-19 11:44:20
Check Details
减少乙肝肝硬化和肝癌的措施
2025-10-19 11:44:20
Check Details
消除乙肝病毒感染的新基因疗法
2025-10-19 11:44:20
Check Details
基因疗法在HBV研发项目中将起到重要作用
2025-10-19 11:44:20
Check Details
乙肝丁肝重叠感染 最严重的肝炎
2025-10-19 11:44:20
Check Details
1
2
...
102
103
104
105
106
107
108
...
504
505
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Is defibrotide included in medical insurance?
2
When was defibrinoside launched on the market?
3
Will defibrination be reimbursed by medical insurance?
4
What conditions is defibrinoside suitable for treating?
5
What is the therapeutic effect of defibrotide?
6
How should defibrinoside be used?
7
What is the effect of defibrotide?
8
Defibrinoside Detailed Instructions
9
What is the effect of defibrination?
10
How effective is defibrotide in the treatment of hepatic veno-occlusive disease?
11
How effective is defibrotide in hepatic veno-occlusive disease?
12
What conditions can defibrotide treat?